
    
      Double-Blind, Randomized, Placebo Controlled Trial of the Safety and Efficacy of DBI-001 Gel
      in Patients with Interdigital Tinea pedis (T. pedis). The primary objective is to observe the
      antimicrobial effect of a daily application of DBI-001Gel for 4 weeks in patients with
      interdigital T. pedis based on the change from culture positive for a dermatophyte to culture
      negative as determined by routine mycology culture.
    
  